Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-05Clinical Trial Update: MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Clinical trial access program for ruxolitinib in polycythemia vera is no longer available.
-
CLINICAL_TRIALS withdrawal · 2016-10-24Clinical Trial Update: Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis [EARLY_Phase 1]
Northwestern University’s early-phase trial of siltuximab for myelofibrosis, including primary, post-polycythemia vera, and post-essential t…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
A clinical trial (NCT02663648) evaluating a cell cycle regulatory gene study in myeloproliferative neoplasms has been withdrawn by the spons…
-
CLINICAL_TRIALS withdrawal · 2014-11-26Clinical Trial Update: Clopidogrel and Aspirin for the Treatment of Polycythemia Vera [Phase 2]
A Phase 2 clinical trial investigating the combination of clopidogrel and aspirin for polycythemia vera was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-20Clinical Trial Update: Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) [Phase 3]
A large Phase 3 trial evaluating the intensity of cytoreductive therapy in polycythemia vera has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.